NEUBASE THERAPEUTICS INC (NBSE) Stock Cash Flow
NASDAQ:NBSE - Nasdaq - US64132K2015 - Common Stock - Currency: USD
| TTM (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | 2020 (2020-9-30) | 2019 (2019-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 20.05M | -33.78M | -25.41M | -17.38M | -26.96M | |||
| Depreciation Amortization | -60.00K | 770.00K | 400.00K | 280.00K | 130.00K | |||
| Change In Working Capital | -2.22M | 180.00K | 360.00K | 480.00K | 620.00K | |||
| Interest Paid | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Taxes Paid | N/A | 0.00 | 0.00 | N/A | 0.00 | |||
| Other non cash items | -3.53M | 3.82M | 5.77M | 5.91M | 23.36M | |||
| OPERATING CASH FLOW | 14.23M | -29.01M | -18.87M | -10.71M | -2.85M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 410.00K | -470.00K | -1.44M | -720.00K | -510.00K | |||
| Other Investing Activity | 10.00K | 0.00 | -1.13M | 0.00 | -180.00K | |||
| INVESTING CASH FLOW | 420.00K | -470.00K | -2.56M | -720.00K | -690.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | -110.00K | -10.00K | 0.00 | 600.00K | |||
| Stock Issued/Repurchased | 4.36M | 0.00 | 42.73M | 33.46M | 13.09M | |||
| Other Financing Activity | 150.00K | -150.00K | -380.00K | -350.00K | -90.00K | |||
| FINANCING CASH FLOW | 4.51M | -260.00K | 42.34M | 33.11M | 13.60M | |||
| CHANGE IN CASH | 19.16M | -29.74M | 20.91M | 21.68M | 10.06M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 14.23M | -29.01M | -18.87M | -10.71M | -2.85M | |||
| Capital Expenditure | 410.00K | -470.00K | -1.44M | -720.00K | -510.00K | |||
| FREE CASH FLOW | 14.64M | -29.48M | -20.31M | -11.43M | -3.36M | |||
All data in USD